Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY).
Auranen A, Powell MA, Sukhin V, Landrum LM, Ronzino G, Buscema J, Bauerschlag D, Lalisang R, Bender D, Gilbert L, Armstrong A, Safra T, Nevadunsky N, Sebastianelli A, Slomovitz B, Ring K, Coleman R, Podzielinski I, Stuckey A, Teneriello M, Gill S, Pothuri B, Willmott L, Sharma S, Dabrowski C, Antony G, Stevens S, Mirza MR, Fleming E. Auranen A, et al. Among authors: antony g. Ther Adv Med Oncol. 2024 Sep 28;16:17588359241277656. doi: 10.1177/17588359241277656. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39346117 Free PMC article.
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study.
Oaknin A, Pothuri B, Gilbert L, Sabatier R, Brown J, Ghamande S, Mathews C, O'Malley DM, Kristeleit R, Boni V, Gravina A, Banerjee S, Miller R, Pikiel J, Mirza MR, Dewal N, Antony G, Dong Y, Zografos E, Veneris J, Tinker AV. Oaknin A, et al. Among authors: antony g. Clin Cancer Res. 2023 Nov 14;29(22):4564-4574. doi: 10.1158/1078-0432.CCR-22-3915. Clin Cancer Res. 2023. PMID: 37363992 Free PMC article.
Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors: A Nonrandomized Controlled Trial.
André T, Berton D, Curigliano G, Sabatier R, Tinker AV, Oaknin A, Ellard S, de Braud F, Arkenau HT, Trigo J, Gravina A, Kristeleit R, Moreno V, Abdeddaim C, Vano YA, Samouëlian V, Miller R, Boni V, Torres AA, Gilbert L, Brown J, Dewal N, Dabrowski C, Antony G, Zografos E, Veneris J, Banerjee S. André T, et al. Among authors: antony g. JAMA Netw Open. 2023 Nov 1;6(11):e2341165. doi: 10.1001/jamanetworkopen.2023.41165. JAMA Netw Open. 2023. PMID: 37917058 Free PMC article. Clinical Trial.
Safety and Efficacy of Dostarlimab in Patients With Recurrent/Advanced Non-small Cell Lung Cancer: Results from Cohort E of the Phase I GARNET Trial.
Moreno V, Roda D, Pikiel J, Trigo J, Bosch-Barrera J, Drew Y, Kristeleit R, Hiret S, Bajor DL, Cruz P, Beck JT, Ghosh S, Dabrowski C, Antony G, Duan T, Veneris J, Zografos E, Subramanian J. Moreno V, et al. Among authors: antony g. Clin Lung Cancer. 2022 Nov;23(7):e415-e427. doi: 10.1016/j.cllc.2022.05.013. Epub 2022 May 23. Clin Lung Cancer. 2022. PMID: 35729005 Free article.
Time to Cure for Childhood and Young Adult Acute Lymphoblastic Leukemia Is Independent of Early Risk Factors: Long-Term Follow-Up of the UKALL2003 Trial.
Moorman AV, Antony G, Wade R, Butler ER, Enshaei A, Harrison CJ, Moppett J, Hough R, Rowntree C, Hancock J, Goulden N, Samarasinghe S, Vora A. Moorman AV, et al. Among authors: antony g. J Clin Oncol. 2022 Dec 20;40(36):4228-4239. doi: 10.1200/JCO.22.00245. Epub 2022 Jun 17. J Clin Oncol. 2022. PMID: 35714315 Clinical Trial.
Erratum to "Nurse-led immunotreatment DEcision Coaching In people with Multiple Sclerosis (DECIMS) - A cluster-randomised controlled trial and mixed methods process evaluation" [Patient Educ Couns 125 (2024) 108293].
Rahn AC, Peper J, Köpke S, Antony G, Liethmann K, Vettorazzi E, Heesen C; DECIMS study group. Rahn AC, et al. Among authors: antony g. Patient Educ Couns. 2024 Nov 12;130:108363. doi: 10.1016/j.pec.2024.108363. Online ahead of print. Patient Educ Couns. 2024. PMID: 39536521 Free article. No abstract available.
Therapeutic drug monitoring in children and adolescents with schizophrenia-spectrum, affective, behavioural, tic and other psychiatric disorders treated with aripiprazole: results of the TDM-VIGIL pharmacovigilance study.
Riegger J, Egberts KM, Clement HW, Schneider-Momm K, Taurines R, Fekete S, Wewetzer C, Karwautz A, Correll CU, Plener PL, Malzahn U, Heuschmann P, Unterecker S, Scherf-Clavel M, Rock H, Antony G, Briegel W, Banaschewski T, Hellenschmidt T, Kaess M, Kölch M, Renner T, Rexroth C, Schulte-Körne G, Walitza S, Gerlach M, Romanos M, Fleischhaker C. Riegger J, et al. Among authors: antony g. J Neural Transm (Vienna). 2024 Nov 2. doi: 10.1007/s00702-024-02819-6. Online ahead of print. J Neural Transm (Vienna). 2024. PMID: 39487894
The impact of the COVID-19 pandemic on administrative eating disorder prevalence in the outpatient sector and on severity of anorexia nervosa.
Tam FI, Ochmann R, Marschall J, Leschzinski H, Seidel M, Klink L, Föcker M, Bühren K, Dahmen B, Jaite C, Herpertz-Dahlmann B, Seitz J, Gilsbach S, Correll CU, Müller AE, Hebebrand J, Bell R, Legenbauer T, Holtmann M, Becker K, Weber L, Romanos M, Egberts K, Kaess M, Fleischhaker C, Möhler E, Wessing I, Hagmann D, Hahn F, Thiemann U, Antony G, Gramatke K, Roessner V, Ehrlich S. Tam FI, et al. Among authors: antony g. Eur Child Adolesc Psychiatry. 2024 Jul 20. doi: 10.1007/s00787-024-02527-2. Online ahead of print. Eur Child Adolesc Psychiatry. 2024. PMID: 39033259 Free article.
2-(10-Bromo-anthracen-9-yl)-N-phenyl-aniline.
Saravanan D, Ponraj C, Khamrang T, Hemamalini M, Antony GJM. Saravanan D, et al. Among authors: antony gjm. IUCrdata. 2024 May 31;9(Pt 5):x240475. doi: 10.1107/S2414314624004759. eCollection 2024 May. IUCrdata. 2024. PMID: 38846551 Free PMC article.
Nurse-led immunotreatment DEcision Coaching In people with Multiple Sclerosis (DECIMS) - A cluster- randomised controlled trial and mixed methods process evaluation.
Rahn AC, Peper J, Köpke S, Antony G, Liethmann K, Vettorazzi E, Heesen C; DECIMS study group. Rahn AC, et al. Among authors: antony g. Patient Educ Couns. 2024 Aug;125:108293. doi: 10.1016/j.pec.2024.108293. Epub 2024 May 3. Patient Educ Couns. 2024. PMID: 38728999 Free article. Clinical Trial.
108 results